Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by Stanford University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00478465
First received: May 23, 2007
Last updated: August 29, 2007
Last verified: August 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2007
  Estimated Primary Completion Date: No date given
No publications provided by Stanford University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):